WORK Medical Technology Group LTD (WOK)

NASDAQ: WOK · Real-Time Price · USD

Compare

1.490

-0.030 (-1.97%)

At close: Feb 17, 2026, 4:00 PM EST

1.460

-0.030 (-2.01%)

After-hours: Feb 17, 2026, 7:53 PM EST

WOK Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Revenue	9.85	11.51	13.57	19.71	45.86
Revenue Growth (YoY)	-14.41%	-15.18%	-31.18%	-57.02%	-12.68%
Cost of Revenue	7.5	8.64	9.42	15.29	37.22
Gross Profit	2.34	2.87	4.14	4.42	8.64
Selling, General & Admin	4.41	6.61	3.43	3.6	4.49
Research & Development	0.44	0.3	0.3	0.18	0.19
Operating Expenses	4.84	6.91	3.73	3.78	4.67
Operating Income	-2.5	-4.05	0.41	0.64	3.97
Interest Expense	-0.5	-0.56	-0.39	-0.35	-0.33
Interest & Investment Income	0.18	0.01	0.03	0	-
Other Non Operating Income (Expenses)	1.74	0.93	0.07	1.19	0.1
EBT Excluding Unusual Items	-1.08	-3.67	0.11	1.47	3.74
Gain (Loss) on Sale of Assets	-	-	-	-0.36	-
Other Unusual Items	-	-	-	-	3.61
Pretax Income	-1.08	-3.67	0.11	1.11	7.34
Income Tax Expense	0.12	-0.13	0.05	0.17	1.08
Earnings From Continuing Operations	-1.2	-3.54	0.06	0.94	6.27
Minority Interest in Earnings	0.13	0.05	0.05	-0.08	-0.31
Net Income	-1.07	-3.49	0.11	0.87	5.96
Net Income to Common	-1.07	-3.49	0.11	0.87	5.96
Net Income Growth	-	-	-87.05%	-85.48%	411.91%
Shares Outstanding (Basic)	0	0	0	-	-
Shares Outstanding (Diluted)	0	0	0	-	-
Shares Change (YoY)	128.13%	1.64%	-	-	-
EPS (Basic)	-3.70	-27.49	0.90	-	-
EPS (Diluted)	-3.70	-27.49	0.90	-	-
Free Cash Flow	4.91	-11.45	1.75	-4.27	-7.24
Free Cash Flow Per Share	16.95	-90.15	14.04	-	-
Gross Margin	23.81%	24.93%	30.54%	22.42%	18.84%
Operating Margin	-25.34%	-35.16%	3.04%	3.24%	8.65%
Profit Margin	-10.89%	-30.35%	0.83%	4.39%	12.99%
Free Cash Flow Margin	49.87%	-99.54%	12.93%	-21.67%	-15.78%
EBITDA	-1.57	-2.63	2.02	3.9	8.16
EBITDA Margin	-15.97%	-22.90%	14.86%	19.77%	17.79%
D&A For EBITDA	0.92	1.41	1.6	3.26	4.19
EBIT	-2.5	-4.05	0.41	0.64	3.97
EBIT Margin	-25.34%	-35.16%	3.04%	3.24%	8.65%
Effective Tax Rate	-	-	42.58%	15.22%	14.69%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q